Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · IEX Real-Time Price · USD
980.16
+10.25 (1.06%)
At close: May 31, 2024, 4:00 PM
980.58
+0.42 (0.04%)
After-hours: May 31, 2024, 7:35 PM EDT

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals had revenue of $13.10B in the twelve months ending March 31, 2024, with 5.90% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.15B, a -0.54% decrease year-over-year. In the year 2023, Regeneron Pharmaceuticals had annual revenue of $13.12B with 7.76% growth.

Revenue (ttm)
$13.10B
Revenue Growth
+5.90%
P/S Ratio
8.11
Revenue / Employee
$973,985
Employees
13,450
Market Cap
106.22B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.12B944.30M7.76%
Dec 31, 202212.17B-3.90B-24.26%
Dec 31, 202116.07B7.57B89.14%
Dec 31, 20208.50B1.94B29.58%
Dec 31, 20196.56B1.41B27.44%
Dec 31, 20185.15B-726.60M-12.37%
Dec 31, 20175.87B1.01B20.82%
Dec 31, 20164.86B756.67M18.44%
Dec 31, 20154.10B1.28B45.55%
Dec 31, 20142.82B714.81M33.96%
Dec 31, 20132.10B726.27M52.69%
Dec 31, 20121.38B932.65M209.20%
Dec 31, 2011445.82M-13.25M-2.89%
Dec 31, 2010459.07M79.81M21.04%
Dec 31, 2009379.27M140.81M59.05%
Dec 31, 2008238.46M113.43M90.73%
Dec 31, 2007125.02M61.58M97.05%
Dec 31, 200663.45M-2.75M-4.15%
Dec 31, 200566.19M-107.82M-61.96%
Dec 31, 2004174.02M116.52M202.65%
Dec 31, 200357.50M35.51M161.49%
Dec 31, 200221.99M15.00K0.07%
Dec 31, 200121.97M-37.30M-62.93%
Dec 31, 200059.28M24.78M71.82%
Dec 31, 199934.50M-3.83M-9.99%
Dec 31, 199838.33M5.23M15.79%
Dec 31, 199733.10M8.99M37.26%
Dec 31, 199624.11M-3.27M-11.94%
Dec 31, 199527.38M4.19M18.08%
Dec 31, 199423.19M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cigna 206.00B
Elevance Health 171.75B
HCA Healthcare 66.72B
Sanofi 51.60B
Bristol-Myers Squibb Company 45.53B
GSK 39.41B
Medtronic 32.32B
Gilead Sciences 27.45B
Revenue Rankings

REGN News

More News